KORA BIOWORKS LTD

Executive Summary

KORA BIOWORKS LTD is currently a dormant company with negligible financial activity and minimal net assets. There is no evidence supporting creditworthiness or ability to service debt. Credit facilities are not recommended until the company demonstrates operational trading and financial viability.

KORA BIOWORKS LTD - Analysis Report

Company Number: 13581457

Analysis Date: 2025-07-29 20:16 UTC

1. Credit Opinion: DECLINE. KORA BIOWORKS LTD is a dormant company with no trading activity or financial data beyond nominal cash and net assets of £1. There is no evidence of operational revenue, profitability, or cash flow generation. The company’s financial inactivity and minimal balance sheet size indicate it currently lacks the capacity to service debt or meet commercial credit obligations.

2. Financial Strength: The balance sheet is extremely limited, showing only £1 in cash and net assets, reflecting share capital of nominal value. No liabilities, revenues, or expenses are recorded, consistent with dormant status. This indicates no financial strength or buffer to absorb shocks or support lending. The company has not demonstrated any growth or asset accumulation since incorporation in 2021.

3. Cash Flow Assessment: Cash and working capital are effectively non-existent beyond £1 in bank funds. The dormant nature means no operating cash inflows or outflows. There is no track record of liquidity management or working capital cycles. This absence of cash flow data precludes any positive assessment of liquidity or debt servicing capability.

4. Monitoring Points:

• Monitor for any future filings that show commencement of trading and generation of revenues.
• Review subsequent accounts for profitability, cash flow, and asset growth before reconsidering credit.
• Track director and ownership changes that might signal business activity or restructuring.
• Watch for changes in filing status or overdue accounts that might indicate financial distress or non-compliance.